Summary |
|
||||||||
Variant origin |
|
||||||||
Variant description |
|
||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:203040Linkage analysis was performed on 150 (129S6/SvEvTac-Scn1atm1Kea x C57BL/6J)F1 x C57BL/6J backcross mice to identify QTL associated with premature lethality in a Dravet syndrome model (Scn1a+/- mice). Phenotype severity in Scn1a+/- mice is strongly dependent on strain background; Scn1a+/- mice exhibit no overt phenotype on the 129S6/SvEvTac background but exhibit spontaneous seizures and early lethality when bred onto a (C57BL/6J x 129S6/SvEvTac)F1 background. For QTL mapping analysis of this backcross the authors used a selective genotyping strategy with single-marker X^2 analysis to identify chronosomes with suggestive evidence of linkage. Under the binary phenotypic trait model, mice were categorized as 'early lethals' (12-week survival) or 'survivors' (=12-week survival). The authors found suggestive or significant evidence for linkage on chromosomes 5 and 11.QTL Dsm4 maps to Chromosome 5 (5.6 - 51.6 cM) with a peak LOD score at 12.9 cM in linkage with premature lethality. The C57BL/6J allele confers increased risk of early death at the Dsm4 locus.QTL Dsm5 maps to Chromosome 11 (4.7 - 39.7 cM) with a peak LOD score at 2.25 cM in linkage with premature lethality. The 129S6/SvEvTac-Scn1atm1Kea allele confers increased risk of early death at the Dsm5 locus. |
||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|